Tidal Investments’s Immunocore IMCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$979K Buy
30,849
+198
+0.6% +$5.86K ﹤0.01% 1755
2026
Q1
$924K Buy
+30,651
New +$992K ﹤0.01% 1511
2024
Q3
Sell
-9,166
Closed -$311K 1902
2024
Q2
$311K Buy
9,166
+2,656
+41% +$135K ﹤0.01% 1518
2024
Q1
$423K Buy
+6,510
New +$447K 0.01% 1256
2023
Q1
Sell
-11,826
Closed -$675K 1332
2022
Q4
$675K Buy
+11,826
New +$666K 0.03% 568

Other funds holding IMCR

Tidal Investments's IMCR Position: Q2 2026 in Review

Tidal Investments increased its Immunocore (IMCR) stake by 0.65% in Q2 2026, buying an estimated $5.86K and bringing the position to 30,849 shares worth $979K. The position accounts for ﹤0.01% of the portfolio, ranked #1755.

Tidal Investments first reported a position in IMCR in Q4 2022 and has held it in 5 quarters since. 135 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Tidal Investments held 30,849 shares of Immunocore worth $979K as of Q2 2026.
  • Tidal Investments bought 198 Immunocore shares in Q2 2026, an estimated $5.86K.
  • Immunocore made up ﹤0.01% of Tidal Investments's portfolio in Q2 2026, its #1755 holding.
  • Tidal Investments first reported a position in Immunocore in Q4 2022 and has held it in 5 quarters since.
  • 135 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.